Phase 3 Pulmonary Arterial Hypertension Clinical Trials
9 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC815 enrolled119 locationsNCT07218029
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension
Insmed Incorporated344 enrolled2 locationsNCT07481981
Recruiting
Phase 3
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
ComorbiditiesCardiovascular Disease (CVD)Pulmonary Arterial Hypertension PAH
Assistance Publique - Hôpitaux de Paris186 enrolled1 locationNCT07245680
Recruiting
Phase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension
Inhibikase Therapeutics486 enrolled2 locationsNCT07365332
Recruiting
Phase 3
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Pulmonary Arterial Hypertension
AOP Orphan Pharmaceuticals AG20 enrolled5 locationsNCT06350032
Recruiting
Phase 3
PAH Exercise Study
Exercise TherapyPulmonary Arterial Hypertension PAH
University of Washington10 enrolled1 locationNCT06941441
Recruiting
Phase 3
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
Pulmonary Arterial Hypertension
University of Arizona20 enrolled1 locationNCT04062565
Recruiting
Phase 2Phase 3
Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation260 enrolled1 locationNCT06683040
Terminated
Phase 3
Scleroderma-Pulmonary Arterial Hypertension Intervention with Apixaban: The SPHInX Study
Pulmonary Arterial HypertensionSystemic Sclerosis
St Vincent's Hospital Melbourne Pty Ltd170 enrolled14 locationsACTRN12614000418673